Clinical Trial Update: Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating imatinib mesylate in combination with vincristine and dexamethasone for Philadelphia chromosome-positive acute lymphoblastic leukemia; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Imatinib mesylate (Imatinib)
• Vincristine (vincristine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Leukemia, Lymphocytic, Acute, Philadelphia Chromosome | Phase 2 | Status: COMPLETED